Prediction In a series of HNSCC patients enrolled into a Phase III trial who received accelerated or standard fractionated RT, high EGFR expression (quantitatively assessed) showed a trend as independent determinant of OS [hazard ratio (95% CI for interaction): 0.75 (0.45-1.25)], PFS (hazard ratio (95% CI for interaction): 0.77 (0.45-1.31) and LRR (hazard ratio (95% CI for interaction): 0.88 (0.46-1.71)] in the accelerated arm, although statistical significance was not reached [ 25 ].
← all excerpts
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.
1
—
—